CMX Research Inc. is pleased to be supporting the HistoSonics, Inc. trial involving the Vortx RX ® to treat Benign Prostatic Hyperplasia (BPH). The Vortx RX® is a portable ultrasound therapy device that is intended for the treatment of BPH by using very intense, low duty-cycle ultrasound pulses. (The Vortx RX is an investigational device and is limited by law …
Aquinox Pharmaceuticals LEADERSHIP Study – AQX-1125-201
Oakville, Ontario – August 26, 2013 – CMX Research Inc. is pleased to announce that it has commenced the clinical phase of the LEADERSHIP Study, where AQX-1125, a potent SHIP1 activator sponsored by Aquinox Pharmaceuticals Inc., is being investigated for the treatment of bladder pain syndrome/interstitial cystitis (BPS/IC). CMX Research Inc. randomized the first patient mid-July, 2013, which was consistent …
Interstitial Cystitis/Bladder Pain Syndrome Clinical Trial
Learn about a research study in your area, testing an investigational treatment for Interstitial Cystitis or Bladder Pain Syndrome. Contact 1-866-666-3329 for further information.
Interstitial Cystitis
Looking for female volunteers with Interstitial Cystitis for a research study testing an investigational medication. Contact 1-866-666-3329 for further information.
Interstitial Cystitis / Bladder Pain Syndrome Clinical Trial
A local urologist in your area is conducting a research study of an investigational medication for women with Interstitial Cystitis/Bladder Pain Syndrome. Contact 1-866-666-3329 for further information.
Women in Clinical Trials
This FDA website is a great resource for women who are interested in participating in clinical trials. http://www.fda.gov/ForConsumers/ByAudience/ForWomen/ucm118508.htm
CMX for Investigators & Academics
CMX supports university, institutional and investigator-led research through our dedicated CMX University
Read More
Clinical Trial Consulting
CMX has established itself as an expert for conducting Phase IV clinical trials that support pharmacovigilance and long-term treatment outcomes. Post-marketing clinical trials speed up the safe and effective transition from research into clinical practice and identify target populations, treatment trends, outcomes and barriers to new medication use. CMX designs innovative Phase IV projects, Investigator Lead Trials (ILT) and comparator …
Patient Recruitment Services
Patient enrollment is often the largest single cause of delays in clinical development and can consume up to one-quarter of the entire clinical development timeline. CMX has been a pioneer in patient recruitment and retention services since 1995. Patient Recruitment Services expedites patient enrollment at each individual investigational site by effective central advertising and call centre referral service. Expertise: CMX …
Site Management Operations (SMO)
CMX manages an extensive investigator network of over 100 research physicians and 120 coordinators with a major specialization in urology. In addition to managing the largest urology network in Canada, CMX also works closely with community and hospital-based researchers who are multidisciplinary in nature. CMX Network Sites: Canadian / US Urology and Oncology Sites Specialties of Network Sites Largest Urology …